Pyridine → 2,4,4'-Trihydroxydeoxybenzoin

HRID 1760763

반응식

HRID 1760763 반응식
FC(F)(F)C(OC(=O)C(F)(F)F)=O.N1C=CC=CC=1.[OH:20][C:21]1(C(F)(F)F)[C:26]2[CH:27]=[CH:28][C:29]([OH:31])=[CH:30][C:25]=2[O:24]C(C2C=CC(OCCN3CCCCC3)=CC=2)[CH:22]1[C:47]1[CH:52]=[CH:51][C:50]([OH:53])=[CH:49][CH:48]=1.C(=O)([O-])[O-].[Na+].[Na+]>C1COCC1.C(OCC)(=O)C>[OH:24][C:25]1[CH:30]=[C:29]([OH:31])[CH:28]=[CH:27][C:26]=1[C:21](=[O:20])[CH2:22][C:47]1[CH:52]=[CH:51][C:50]([OH:53])=[CH:49][CH:48]=1

참가 물질

7

실험 절차

0.88 ml of trifluoroacetic acid anhydride and 1.37 ml of pyridine are simultaneously added in drops to 1.15 g of 4,7-dihydroxy-3-(4-hydroxyphenyl)-2-[4-(2-piperidin-1-ylethoxy) -phenyl]-4-(trifluoromethyl)-2,3-dihydro-4H-1-benzopyran in 20 ml of THF. It is stirred for 4 hours at room temperature before 70 ml of ethyl acetate and 20 ml of 10% sodium carbonate solution are added. It is stirred for 20 more minutes at room temperature. The phases are separated, and the aqueous phase is shaken out three times with 40 ml of ethyl acetate. The combined organic phases are washed twice with 20 ml of water, dried on magnesium sulfate and concentrated by evaporation. The product is prepurified on silica gel with dichloromethane/methanol and then purified with HPLC (nucleosil 50-7, dichloromethane/methanol 85:15, 40 ml/min). 590 mg is obtained.

후처리

  1. additionare added
  2. customThe phases are separated
  3. stirringthe aqueous phase is shaken out three times with 40 ml of ethyl acetate
  4. washThe combined organic phases are washed twice with 20 ml of water
  5. customdried on magnesium sulfate
  6. concentrationconcentrated by evaporation
  7. custompurified with HPLC (nucleosil 50-7, dichloromethane/methanol 85:15, 40 ml/min)
  8. custom590 mg is obtained

출처 및 근거

ORD 기록
ord-f1614aa6f5ea4a6ea4c7928fb712567a
출처 데이터셋
uspto-grants-2005_01
특허 번호
US06844336B2

연결된 노트

불러오는 중…